加载中
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
前收盘价
US$0.521
+US$0.041 · +8.54%
盘中时间采用ET。市场数据可能有所延迟。
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
日内区间
当前US$0.521
52周区间
当前US$0.521
盘中时间采用ET。市场数据可能有所延迟。
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
日内区间
当前US$0.521
52周区间
当前US$0.521
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 897.9万 USD | 700.9万 USD | 620.5万 USD | 517.1万 USD | 449.5万 USD |
| 销货成本 | 633万 USD | 550.3万 USD | 439.8万 USD | 405.4万 USD | 374.1万 USD |
| 毛利 | 264.9万 USD | 150.6万 USD | 180.7万 USD | 111.7万 USD | 75.4万 USD |
| 研究与开发 | 1500.3万 USD | 1363.4万 USD | 798.1万 USD | 781万 USD | 515.8万 USD |
| 销售、一般及管理费用 | 3726万 USD | 2137.5万 USD | 1496.9万 USD | 1202万 USD | 1031.2万 USD |
| 营业费用 | 5176.1万 USD | 3500.9万 USD | 2295万 USD | 1983万 USD | 1547万 USD |
| 利息收入 | — | 155.7万 USD | 129.2万 USD | 25万 USD | — |
| 利息支出 | — | — | — | — | 15.7万 USD |
| 折旧和摊销 | 47.6万 USD | 28万 USD | 23.2万 USD | 18.8万 USD | 16.1万 USD |
| 营业利润 | −4911.2万 USD | −3350.3万 USD | −2114.3万 USD | −1871.3万 USD | −1471.6万 USD |
| 净利润 | −4878.6万 USD | −3200.5万 USD | −1991.6万 USD | −1849.1万 USD | −1491.8万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$3.50
上涨空间 571.79%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2021年4月27日 | 1:15 | — | — |
股票拆分 | 2019年4月1日 | 1:50 | — | — |
股票拆分 | 2018年2月8日 | 1:35 | — | — |
股票拆分 | 2016年10月10日 | 1:25 | — | — |
股票拆分 | 2015年10月1日 | 1:10 | — | — |
股票拆分 | 2012年12月21日 | 1:4 | — | — |
已生效 2021年4月27日
1:15
已生效 2019年4月1日
1:50
已生效 2018年2月8日
1:35
已生效 2016年10月10日
1:25
已生效 2015年10月1日
1:10
已生效 2012年12月21日
1:4
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
